Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cardiac Maker Analyzer Product Analysis & Marketing Strategies

Renub Research
Posted on: 02 Aug 17
Cardiac Maker Analyzer Product Analysis & Marketing Strategies

Download full Report:


Renub Research recently published a report on “Cardiac Maker Analyzer Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies”. The report comprises in-depth analysis by company (products specifications, comparative tests analysis, merger, acquisitions, and agreements), sales & Forecast to 2022.

Cardiac Markers Analyzers generally measure the levels of enzymes and proteins that are linked with injury of the heart muscle. When any damage to the heart muscle occurs, the levels of cardiac markers rise over time that is why blood tests for myocardial infarction are taken over a 24-hour period. These enzymes include Creatine Kinase (CK), Myoglobin, Brain Natriuretic Peptide (BNP), and the proteins Troponin I (TnI), Troponin T (TnT) .

Cardiac troponin levels usually remain too low; hence, they cannot be detected with most blood tests and when they are detected, it's usually represents that the heart muscle got damaged due to a myocardial infarction commonly termed as Heart attack. Troponin levels may also remain high for up to 14 days after a heart attack strikes.

Today, a number of companies focused their interest in the development of advanced and highly efficient cardiac markers that perform several cardiac marker tests on their cardio-metabolism platform and established them as the leader in this market. Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also offer several cardiac marker tests on their cardio-metabolism platform.

Alere Inc., a renowned name in rapid diagnostic tests, provides reliable and actionable health information through cardiac marker tests, ensuing in better clinical outcomes. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule the industry rigorously in the coming future.

Cardiac Marker Analyzers are important for the prevention of the misdiagnoses of cardiac conditions.

A Cardiac Marker Analyzer increases its efficacy and accuracy with special features, such as software, which provides an internal standard to diagnostic procedures and built in LCD displays for the visualization of practices.

The Report Studies the 12 Companies Cardiac Marker Analyzer Product Specifications, Merger, Expansion and Distribution Plans
1. Alere
2. Response Biomedical
3. Abbott Point of Care
4. Roche
5. Siemens Healthineers
6. Beckman Coulter
7. Boditech
8. Lifesign
9. LSI Medience Corporation
10. Trinity Biotech
11. CardioGenics Holdings Inc.
12. Getein Biotechnology


Contact Us

Rajat Gupta

Sr. Marketing Manager


Phone: +1-678-302-0700


For more information:

Editor's Details

Rajat Gupta
Renub Research

Last updated on: 02/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.